US6361943B1
(en)
*
|
1996-10-17 |
2002-03-26 |
Mitsubishi Chemical Corporation |
Molecule that homologizes genotype and phenotype and utilization thereof
|
WO1990005144A1
(en)
*
|
1988-11-11 |
1990-05-17 |
Medical Research Council |
Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
|
US8207093B2
(en)
|
1997-01-21 |
2012-06-26 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US6261804B1
(en)
*
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
EP1801214B1
(en)
|
1997-07-07 |
2010-11-10 |
Medical Research Council |
In vitro sorting method
|
US6242246B1
(en)
*
|
1997-12-15 |
2001-06-05 |
Somalogic, Inc. |
Nucleic acid ligand diagnostic Biochip
|
US20070166741A1
(en)
*
|
1998-12-14 |
2007-07-19 |
Somalogic, Incorporated |
Multiplexed analyses of test samples
|
WO1999051773A1
(en)
*
|
1998-04-03 |
1999-10-14 |
Phylos, Inc. |
Addressable protein arrays
|
US6440695B1
(en)
*
|
1998-04-17 |
2002-08-27 |
Whitehead Institute For Biomedical Research |
Method for producing diverse libraries of encoded polypeptides
|
US20030170820A1
(en)
*
|
1998-05-08 |
2003-09-11 |
Gregory Coia |
Continuous in- vitro evolution
|
JP4240574B2
(ja)
*
|
1998-05-15 |
2009-03-18 |
三菱化学株式会社 |
タンパク質のラベル化組成物およびタンパク質のラベル化方法
|
US6287765B1
(en)
*
|
1998-05-20 |
2001-09-11 |
Molecular Machines, Inc. |
Methods for detecting and identifying single molecules
|
AU757955B2
(en)
*
|
1998-08-17 |
2003-03-13 |
Bristol-Myers Squibb Company |
Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
|
EP1105516A4
(en)
*
|
1998-08-17 |
2002-01-09 |
Phylos Inc |
METHODS FOR PRODUCING PRIVATE NUCLEIC ACIDS FROM 3 'NON-TRANSLATED REGIONS AND FOR OPTIMIZING THE FORMATION OF A CELL-PROTEIN RNA FUSION
|
AU2004200998B2
(en)
*
|
1998-08-17 |
2007-01-11 |
Compound Therapeutics, Inc. |
Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular RNA-protein fusion formation
|
ES2280131T3
(es)
|
1998-12-02 |
2007-09-01 |
Adnexus Therapeutics, Inc. |
Fusiones de adn-proteina y utilizaciones de las mismas.
|
US7115396B2
(en)
*
|
1998-12-10 |
2006-10-03 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
US6818418B1
(en)
*
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
AU775076B2
(en)
|
1998-12-10 |
2004-07-15 |
Bristol-Myers Squibb Company |
Protein scaffolds for antibody mimics and other binding proteins
|
AU2004242526B2
(en)
*
|
1999-01-07 |
2007-08-30 |
United Kingdom Research And Innovation |
Optical Sorting Method
|
GB9900298D0
(en)
*
|
1999-01-07 |
1999-02-24 |
Medical Res Council |
Optical sorting method
|
WO2000061815A1
(en)
|
1999-04-12 |
2000-10-19 |
The Johns Hopkins University School Of Medicine |
In vitro ribosome evolution
|
DE19923966C2
(de)
*
|
1999-05-25 |
2003-04-24 |
Phylos Inc |
Erkennungssystem zur Auftrennung von Probenbestandteilen, seine Herstellung und Verwendung
|
JP2003500081A
(ja)
|
1999-06-01 |
2003-01-07 |
フィロス インク. |
5’核酸−タンパク質結合体の生成法
|
AU778194B2
(en)
|
1999-07-12 |
2004-11-18 |
Bristol-Myers Squibb Company |
C-terminal protein tagging
|
AU2008200974B2
(en)
*
|
1999-07-27 |
2012-05-03 |
Bristol-Myers Squibb Company |
Peptide acceptor ligation methods
|
PT1196637E
(pt)
*
|
1999-07-27 |
2007-07-04 |
Adnexus Therapeutics Inc |
Métodos de ligação de aceitadores de péptidos.
|
WO2001016352A1
(en)
|
1999-08-27 |
2001-03-08 |
Phylos, Inc. |
Methods for encoding and sorting in vitro translated proteins
|
EP1226149A4
(en)
*
|
1999-10-01 |
2003-05-14 |
Zhongping Yu |
COMPOSITIONS AND METHODS FOR IDENTIFYING NUCLEIC ACID POLYPETIDES AND MOLECULES
|
DE19959857C1
(de)
*
|
1999-12-10 |
2001-06-28 |
Aventis Res & Tech Gmbh & Co |
Testsystem zum Nachweis von Analyten sowie ein Verfahren zur Herstellung und Verwendung
|
SG121902A1
(en)
*
|
2000-01-11 |
2006-05-26 |
Maxygen Inc |
Integrated systems for diversity generation and screening
|
US6489116B2
(en)
*
|
2000-01-24 |
2002-12-03 |
Phylos, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
US7022479B2
(en)
*
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
EP1266035A4
(en)
*
|
2000-02-24 |
2003-09-17 |
Phylos Inc |
IMPROVED METHODS OF PRODUCING CATAYTIC PROTEINS
|
US6489106B1
(en)
*
|
2000-03-10 |
2002-12-03 |
Nec Research Institute, Inc. |
Control of the expression of anchored genes using micron scale heaters
|
US8288322B2
(en)
|
2000-04-17 |
2012-10-16 |
Dyax Corp. |
Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
|
WO2001083507A1
(en)
*
|
2000-05-05 |
2001-11-08 |
Selegen |
Identification of polypeptides and nucleic acid molecules using linkage between dna and polypeptide
|
US7410761B2
(en)
|
2000-05-19 |
2008-08-12 |
Proteonova, Inc. |
System for rapid identification and selection of nucleic acids and polypeptides, and method thereof
|
US20040229271A1
(en)
|
2000-05-19 |
2004-11-18 |
Williams Richard B. |
Compositions and methods for the identification and selection of nucleic acids and polypeptides
|
EP1290222B1
(en)
*
|
2000-05-19 |
2007-08-08 |
Richard B. Williams |
In vitro evolution of nucleic acids and encoded polypeptide
|
US6962781B1
(en)
|
2000-05-19 |
2005-11-08 |
Proteonova, Inc. |
In vitro evolution of nucleic acids and encoded polypeptide
|
JP4955185B2
(ja)
|
2000-06-29 |
2012-06-20 |
アボット・ラボラトリーズ |
二重特異性抗体ならびに作製方法および使用方法
|
DE10033194C2
(de)
*
|
2000-07-07 |
2002-07-18 |
Aventis Res & Tech Gmbh & Co |
Biosonden und deren Verwendung
|
DK1309861T3
(da)
*
|
2000-08-15 |
2006-10-23 |
Discerna Ltd |
Funktionelle protein-arrays
|
DE10041238A1
(de)
*
|
2000-08-22 |
2002-03-07 |
Aventis Res & Tech Gmbh & Co |
Verfahren zur Identifizierung spezifisch spaltbarer peptide und Verwendung solcher Peptidsequenzen
|
CA2420325A1
(en)
|
2000-08-25 |
2002-02-28 |
Basf Plant Science Gmbh |
Plant polynucleotides encoding novel prenyl proteases
|
AU1325102A
(en)
|
2000-10-16 |
2002-04-29 |
Phylos Inc |
Protein scaffolds for antibody mimics and other binding proteins
|
US6841359B2
(en)
|
2000-10-31 |
2005-01-11 |
The General Hospital Corporation |
Streptavidin-binding peptides and uses thereof
|
JP4516273B2
(ja)
*
|
2000-11-15 |
2010-08-04 |
ミナーヴァ・バイオテクノロジーズ・コーポレーション |
オリゴヌクレオチド識別子
|
EP1350846A4
(en)
*
|
2000-12-07 |
2005-01-26 |
Univ Keio |
C-TERMINAL MODIFIED PROTEIN AND METHOD FOR THE PRODUCTION THEREOF, IN THE PREPARATION OF C-TERMINAL MODIFIED PROTEIN TO BE USED, AND TRANSLATION TEMPLATE AND METHOD FOR DETECTING PROTEIN CHANGING EFFECT USING THE C-TERMINAL MODIFIED PROTEIN
|
JP4963142B2
(ja)
*
|
2000-12-14 |
2012-06-27 |
学校法人慶應義塾 |
遺伝子型と表現型の対応付け分子とその構成要素、および対応付け分子の製造方法と利用方法
|
ES2409080T3
(es)
*
|
2001-01-22 |
2013-06-24 |
Sangamo Biosciences Inc. |
Proteínas de unión con dedos de zinc modificadas
|
CA2434139C
(en)
|
2001-01-23 |
2014-05-27 |
President And Fellows Of Harvard College |
Nucleic-acid programmable protein arrays
|
EP1423400B2
(en)
*
|
2001-03-19 |
2013-05-22 |
President and Fellows of Harvard College |
Evolving new molecular function
|
EP1507860A4
(en)
*
|
2001-04-02 |
2005-08-03 |
Univ Washington |
REFERENCE TOOLS FOR DYNAMIC ACTIONS
|
AU2002256076A1
(en)
*
|
2001-04-10 |
2002-10-28 |
Interlock Industries, Inc. |
Water based adhesive
|
JP2008099700A
(ja)
*
|
2001-05-11 |
2008-05-01 |
National Institute Of Advanced Industrial & Technology |
任意のポリペプチドをコードするDNAの転写産物と翻訳産物との安定的な複合体を形成させる方法、該方法に用いる核酸構築物、該方法により形成される複合体、並びに該方法を利用した機能性タンパク質および該タンパク質をコードするmRNAまたはDNAのスクリーニング
|
EP1402024B1
(en)
*
|
2001-06-20 |
2007-08-22 |
Nuevolution A/S |
Templated molecules and methods for using such molecules
|
US7727713B2
(en)
|
2001-06-20 |
2010-06-01 |
Nuevolution A/S |
Templated molecules and methods for using such molecules
|
US20060234231A1
(en)
*
|
2001-06-20 |
2006-10-19 |
Nuevolution A/S |
Microarrays displaying encoded molecules
|
US20040161741A1
(en)
*
|
2001-06-30 |
2004-08-19 |
Elazar Rabani |
Novel compositions and processes for analyte detection, quantification and amplification
|
US9777312B2
(en)
|
2001-06-30 |
2017-10-03 |
Enzo Life Sciences, Inc. |
Dual polarity analysis of nucleic acids
|
US20030143612A1
(en)
*
|
2001-07-18 |
2003-07-31 |
Pointilliste, Inc. |
Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
|
EP1419274A4
(en)
*
|
2001-07-31 |
2006-02-08 |
Phylos Inc |
MODULAR CONSTRUCTION OF NUCLEIC ACID PROTEIN FUSION MULTIMERS
|
US7172905B2
(en)
*
|
2001-08-07 |
2007-02-06 |
The University Of Chicago |
Polypeptide immobilization
|
DE10147074A1
(de)
*
|
2001-09-25 |
2003-05-08 |
Beru Ag |
Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung
|
GB0127564D0
(en)
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
CA2467836A1
(en)
|
2001-11-20 |
2003-09-04 |
Duke University |
Interfacial biomaterials
|
WO2003045975A2
(en)
*
|
2001-11-27 |
2003-06-05 |
Compound Therapeutics, Inc. |
Solid-phase immobilization of proteins and peptides
|
US7262054B2
(en)
*
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
DE20200926U1
(de)
*
|
2002-01-23 |
2002-04-18 |
Hegenscheidt Mfd Gmbh & Co Kg |
Festwalzgerät einer Festwalzmaschine für Kurbelwellen
|
JP2003299489A
(ja)
*
|
2002-02-08 |
2003-10-21 |
Mitsubishi Chemicals Corp |
核酸構築物
|
AU2003217379A1
(en)
*
|
2002-02-15 |
2003-09-09 |
Somalogic, Inc. |
Methods and reagents for detecting target binding by nucleic acid ligands
|
US20050247001A1
(en)
*
|
2002-03-15 |
2005-11-10 |
Nuevolution A/S |
Building block forming a c-c or a c-hetero atom bond uponreaction
|
WO2003078050A2
(en)
*
|
2002-03-15 |
2003-09-25 |
Nuevolution A/S |
A building block forming a c-c bond upon reaction
|
AU2003214033A1
(en)
*
|
2002-03-15 |
2003-09-29 |
Nuevolution A/S |
A building block capable of transferring a functional entity
|
EP1487978B1
(en)
|
2002-03-15 |
2008-11-19 |
Nuevolution A/S |
An improved method for synthesising templated molecules
|
NO20021298L
(no)
*
|
2002-03-15 |
2003-09-16 |
Bjoern H Lindqvist |
Metoder for peptid og protein påvisning i nukleinsyre chip- arrays
|
US20030235852A1
(en)
*
|
2002-04-19 |
2003-12-25 |
Roberts Richard W. |
Nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues, and methods of making same using peptide modifying agents
|
US20060073481A1
(en)
*
|
2002-04-23 |
2006-04-06 |
The Molecular Sciences Institute |
Formation and use of site specific nucleic acid coupled binding polypeptides
|
US20030198967A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Matson Robert S. |
Multi-functional microarrays and methods
|
US20030198973A1
(en)
*
|
2002-04-23 |
2003-10-23 |
The Molecular Sciences Institute, Inc. |
Chimeric fusion molecule for analyte detection and quantitation
|
EP1520040A2
(en)
*
|
2002-06-20 |
2005-04-06 |
Nuevolution A/S |
Microarrays displaying encoded molecules
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
EP1521961A2
(en)
*
|
2002-07-05 |
2005-04-13 |
The University of Chicago |
Characterization of biochips containing self-assembled monolayers with maldi-tof-ms
|
USRE47770E1
(en)
|
2002-07-18 |
2019-12-17 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
DK2314629T4
(da)
*
|
2002-07-18 |
2023-02-06 |
Merus Nv |
Rekombinant produktion af blandinger af antistoffer
|
US10730906B2
(en)
|
2002-08-01 |
2020-08-04 |
Nuevolutions A/S |
Multi-step synthesis of templated molecules
|
JP4657919B2
(ja)
*
|
2002-08-19 |
2011-03-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
進化する新しい分子機能
|
US20040043384A1
(en)
*
|
2002-08-28 |
2004-03-04 |
Oleinikov Andrew V. |
In vitro protein translation microarray device
|
US7361635B2
(en)
*
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
US7112552B2
(en)
*
|
2002-10-18 |
2006-09-26 |
Promega Corporation |
Compositions for separating molecules
|
CN106337046B
(zh)
*
|
2002-10-30 |
2021-03-23 |
纽韦卢森公司 |
合成双功能复合物的方法
|
AU2011226815B2
(en)
*
|
2002-10-30 |
2014-09-25 |
Nuevolution A/S |
Enzymatic encoding
|
WO2004056994A2
(en)
|
2002-12-19 |
2004-07-08 |
Nuevolution A/S |
Quasirandom structure and function guided synthesis methods
|
US7083948B1
(en)
*
|
2002-12-24 |
2006-08-01 |
Immunex Corporation |
Polypeptide purification reagents and methods for their use
|
EP2159285B1
(en)
|
2003-01-29 |
2012-09-26 |
454 Life Sciences Corporation |
Methods of amplifying and sequencing nucleic acids
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
KR100858081B1
(ko)
*
|
2003-02-14 |
2008-09-10 |
삼성전자주식회사 |
유전정보 코딩장치 및 방법
|
WO2004074501A2
(en)
*
|
2003-02-21 |
2004-09-02 |
Nuevolution A/S |
A method for obtaining structural information about an encoded molecule
|
EP1597395A2
(en)
*
|
2003-02-21 |
2005-11-23 |
Nuevolution A/S |
Method for producing second-generation library
|
US20100022414A1
(en)
|
2008-07-18 |
2010-01-28 |
Raindance Technologies, Inc. |
Droplet Libraries
|
EP2236606B1
(en)
*
|
2003-03-20 |
2013-11-06 |
Nuevolution A/S |
Ligational encoding of small molecules
|
US8017323B2
(en)
*
|
2003-03-26 |
2011-09-13 |
President And Fellows Of Harvard College |
Free reactant use in nucleic acid-templated synthesis
|
WO2004087730A2
(en)
*
|
2003-03-27 |
2004-10-14 |
The Johns Hopkins University |
Method for producing diverse libraries of encoded polymers
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
WO2004101620A2
(en)
*
|
2003-05-01 |
2004-11-25 |
Compound Therapeutics, Inc. |
Serum albumin scaffold-based proteins and uses thereof
|
AU2004242614B2
(en)
|
2003-05-30 |
2011-09-22 |
Merus N.V. |
Fab library for the preparation of anti vegf and anti rabies virus fabs
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
WO2004110964A2
(en)
*
|
2003-06-16 |
2004-12-23 |
Nuevolution A/S |
Encoded molecules by translation (emt)
|
JP5183063B2
(ja)
|
2003-07-05 |
2013-04-17 |
ザ ジョンズ ホプキンス ユニバーシティ |
遺伝的変異の検出および列挙のための方法ならびに組成物
|
EP1660186B1
(en)
|
2003-08-18 |
2013-12-25 |
MedImmune, LLC |
Humanization of antibodies
|
DK1670939T3
(da)
|
2003-09-18 |
2010-03-01 |
Nuevolution As |
Fremgangsmåde til opnåelse af strukturel information om et kodet molekyle og fremgangsmåde til udvælgelse af forbindelser
|
US20080220049A1
(en)
*
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
TW200531979A
(en)
|
2003-12-05 |
2005-10-01 |
Compound Therapeutics Inc |
Inhibitors of type 2 vascular endothelial growth factor receptors
|
ES2646560T3
(es)
|
2004-01-20 |
2017-12-14 |
Merus N.V. |
Mezclas de proteínas de unión
|
WO2005078122A2
(en)
*
|
2004-02-17 |
2005-08-25 |
Nuevolution A/S |
Method for enrichment involving elimination by mismatch hybridisation
|
DK1730277T3
(da)
|
2004-03-22 |
2010-03-01 |
Nuevolution As |
Kodning ved ligering under anvendelse af byggebloksoligonukleotider
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
US20060008844A1
(en)
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
CA2839092C
(en)
*
|
2004-08-03 |
2018-04-03 |
Becton, Dickinson And Company |
Use of magnetic material to direct isolation of compounds and fractionation of multipart samples
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
AU2005322131B2
(en)
*
|
2004-12-23 |
2011-11-10 |
Global Life Sciences Solutions Usa Llc |
Ligation-based RNA amplification
|
EP1846432A4
(en)
*
|
2005-01-12 |
2008-11-19 |
Proteonova Inc |
METHOD FOR MANUFACTURING TARGETED THERAPEUTIC AGENTS
|
US10206998B2
(en)
|
2005-01-12 |
2019-02-19 |
Proteonova, Inc. |
Modular targeted therapeutic agents and methods of making same
|
AU2006227377B2
(en)
|
2005-03-18 |
2013-01-31 |
Medimmune, Llc |
Framework-shuffling of antibodies
|
WO2007011722A2
(en)
|
2005-07-15 |
2007-01-25 |
President And Fellows Of Harvard College |
Reaction discovery system
|
CN101370525B
(zh)
|
2005-08-19 |
2013-09-18 |
Abbvie公司 |
双重可变结构域免疫球蛋白及其用途
|
EP2500356A3
(en)
|
2005-08-19 |
2012-10-24 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
CA2624562A1
(en)
|
2005-09-30 |
2007-04-12 |
Abbott Gmbh & Co. Kg |
Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use
|
EP1785434A1
(en)
|
2005-11-11 |
2007-05-16 |
Ludwig-Maximilians-Universität München |
Targeting and tracing of antigens in living cells
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
EP2392588A3
(en)
|
2005-11-11 |
2012-03-07 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
ES2547554T3
(es)
|
2005-11-16 |
2015-10-07 |
Ambrx, Inc. |
Métodos y composiciones que comprenden aminoácidos no naturales
|
PL1976877T5
(pl)
|
2005-11-30 |
2017-09-29 |
Abbvie Inc |
Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
|
CN117903302A
(zh)
|
2005-11-30 |
2024-04-19 |
Abbvie 公司 |
抗-Aβ球聚体抗体,其相关产品,生产所述抗体的方法,所述抗体的应用以及使用方法
|
DK2336315T3
(da)
|
2005-12-01 |
2017-11-06 |
Nuevolution As |
Fremgangsmåde til enzymatisk kodning ved effektiv syntese af store biblioteker
|
WO2008010837A2
(en)
*
|
2005-12-15 |
2008-01-24 |
The Regents Of The University Of California |
Noncompetitive immunoassays to detect small molecules
|
EP3913375A1
(en)
|
2006-01-11 |
2021-11-24 |
Bio-Rad Laboratories, Inc. |
Microfluidic devices and methods of use in the formation and control of nanoreactors
|
HUE025489T2
(en)
*
|
2006-01-17 |
2016-04-28 |
Somalogic Inc |
Multiplexed analysis of test samples
|
JP5259423B2
(ja)
|
2006-02-01 |
2013-08-07 |
セファロン・オーストラリア・ピーティーワイ・リミテッド |
ドメイン抗体構築物
|
WO2007092777A2
(en)
*
|
2006-02-02 |
2007-08-16 |
Wyeth |
Cloning, characterization, and application of tnfrsf19 in neurological disorders
|
US7749957B2
(en)
|
2006-04-06 |
2010-07-06 |
E.I. Du Pont De Nemours And Company |
Clay-binding peptides and methods of use
|
EP2481815B1
(en)
|
2006-05-11 |
2016-01-27 |
Raindance Technologies, Inc. |
Microfluidic devices
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
US8178316B2
(en)
|
2006-06-29 |
2012-05-15 |
President And Fellows Of Harvard College |
Evaluating proteins
|
US9110054B2
(en)
|
2006-06-30 |
2015-08-18 |
Discoverx Corporation |
Detectable nucleic acid tag
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
EP2069534A4
(en)
*
|
2006-08-02 |
2010-08-11 |
California Inst Of Techn |
METHODS AND SYSTEMS FOR DETECTING AND / OR SORTING TARGETS
|
WO2008021123A1
(en)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
ES2902063T3
(es)
|
2006-09-08 |
2022-03-24 |
Abbvie Bahamas Ltd |
Proteínas de unión a interleucina-13
|
US20090252745A1
(en)
*
|
2006-09-15 |
2009-10-08 |
Duke University |
Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis
|
US8470332B2
(en)
|
2006-11-22 |
2013-06-25 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
EP2114443A4
(en)
|
2006-12-29 |
2011-08-10 |
Abbott Lab |
IL-1A / IL-1B ANTIBODY WITH DOUBLE SPECIFICITY
|
US7855054B2
(en)
*
|
2007-01-16 |
2010-12-21 |
Somalogic, Inc. |
Multiplexed analyses of test samples
|
US20110136099A1
(en)
|
2007-01-16 |
2011-06-09 |
Somalogic, Inc. |
Multiplexed Analyses of Test Samples
|
EP2111228B1
(en)
|
2007-02-02 |
2011-07-20 |
Bristol-Myers Squibb Company |
10Fn3 domain for use in treating diseases associated with inappropriate angiogenesis
|
WO2008097559A2
(en)
|
2007-02-06 |
2008-08-14 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
AU2008216303A1
(en)
|
2007-02-12 |
2008-08-21 |
Proteonova, Inc. |
Generation of library of soluble random polypeptides linked to mRNA
|
EP2486928A1
(en)
|
2007-02-27 |
2012-08-15 |
Abbott GmbH & Co. KG |
Method for the treatment of amyloidoses
|
WO2008130623A1
(en)
|
2007-04-19 |
2008-10-30 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
US7678883B2
(en)
|
2007-07-25 |
2010-03-16 |
E.I. Du Pont De Nemours And Company |
Solubility tags for the expression and purification of bioactive peptides
|
US7829311B2
(en)
|
2007-07-25 |
2010-11-09 |
E.I. Du Pont De Nemours And Company |
Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
|
US7951559B2
(en)
*
|
2007-07-25 |
2011-05-31 |
E.I. Du Pont De Nemours And Company |
Recombinant peptide production using a cross-linkable solubility tag
|
US8680019B2
(en)
*
|
2007-08-10 |
2014-03-25 |
Protelica, Inc. |
Universal fibronectin Type III binding-domain libraries
|
US8470966B2
(en)
|
2007-08-10 |
2013-06-25 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
AU2008287426B2
(en)
*
|
2007-08-10 |
2014-06-26 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
CA2697193C
(en)
|
2007-09-14 |
2017-06-06 |
Adimab, Inc. |
Rationally designed, synthetic antibody libraries and uses therefor
|
US7794963B2
(en)
|
2007-11-02 |
2010-09-14 |
E.I. Du Pont De Nemours And Company |
Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
|
KR20100091170A
(ko)
|
2007-11-02 |
2010-08-18 |
노파르티스 아게 |
저밀도-지단백질 수용체-관련 단백질 6 (lrp6)을 조정하기 위한 분자 및 방법
|
US8906700B2
(en)
|
2007-11-06 |
2014-12-09 |
Ambergen, Inc. |
Methods and compositions for phototransfer
|
SG10201604258YA
(en)
|
2007-11-30 |
2016-07-28 |
Abbvie Biotechnology Ltd |
Anti-tnf antibody formulations
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
US8716437B2
(en)
*
|
2007-12-07 |
2014-05-06 |
Steven A. Goldstein |
Identification of toxin ligands
|
MX2010008874A
(es)
|
2008-02-14 |
2010-09-22 |
Bristol Myers Squibb Co |
Terapeuticos dirigidos a base de proteinas manipuladas que se unen al receptor de factor de crecimiento epidermico.
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
US9873957B2
(en)
|
2008-03-13 |
2018-01-23 |
Dyax Corp. |
Libraries of genetic packages comprising novel HC CDR3 designs
|
EP3141905B1
(en)
|
2008-03-27 |
2019-03-06 |
Promega Corporation |
Protein labeling with cyanobenzothiazole conjugates
|
DK2281078T3
(en)
|
2008-04-24 |
2015-02-02 |
Dyax Corp |
LIBRARIES OF RE-PACKAGES INCLUDING UNKNOWN HC-CDR1, -CDR2 AND -CDR3 AND UNKNOWN LC-CDR1, -CDR2 AND-CDR3 DESIGNS
|
BR122021026834B1
(pt)
|
2008-04-25 |
2022-11-08 |
Takeda Pharmaceutical Company Limited |
Anticorpos isolados que se ligam a fcrn, composição farmacêutica que compreende os mesmos e métodos para detectar e para modular fcrn
|
SG190572A1
(en)
|
2008-04-29 |
2013-06-28 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
JP2011521626A
(ja)
|
2008-05-02 |
2011-07-28 |
エピセンター テクノロジーズ コーポレーション |
Rnaポリホスファターゼの組成物、キットおよびそれらの使用
|
US8323651B2
(en)
|
2008-05-09 |
2012-12-04 |
Abbott Laboratories |
Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
|
CN102099373A
(zh)
|
2008-05-22 |
2011-06-15 |
百时美施贵宝公司 |
基于纤连蛋白的多价支架结构域蛋白
|
KR20110016959A
(ko)
|
2008-06-03 |
2011-02-18 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
AR072001A1
(es)
|
2008-06-03 |
2010-07-28 |
Abbott Lab |
Inmunoglobulina con dominio variable dual y usos de la misma
|
MX344076B
(es)
|
2008-06-30 |
2016-12-05 |
Esbatech Alcon Biomed Res Unit |
Polipeptidos funcionalizados.
|
RU2011104348A
(ru)
|
2008-07-08 |
2012-08-20 |
Эбботт Лэборетриз (Us) |
Иммуноглобулины с двойным вариабельным доменом против простагландина е2 и их применение
|
EP2310049A4
(en)
|
2008-07-08 |
2013-06-26 |
Abbvie Inc |
PROSTAGLANDIN E2 BINDING PROTEINS AND USES THEREOF
|
JP5924937B2
(ja)
|
2008-07-25 |
2016-05-25 |
エックス−ボディ インコーポレイテッド |
タンパク質スクリーニング法
|
RU2011117213A
(ru)
*
|
2008-09-30 |
2012-11-10 |
Эббот Лэборетриз (Us) |
Улучшенные библиотеки антител
|
CA2740440A1
(en)
|
2008-10-14 |
2010-04-22 |
Dyax Corp. |
Use of igf-ii/igf-iie binding proteins for the treatment and prevention of systemic sclerosis-associated pulmonary fibrosis
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之egfr/igfir結合分子
|
US8697654B2
(en)
|
2008-12-18 |
2014-04-15 |
E I Du Pont De Nemours And Company |
Peptide linkers for effective multivalent peptide binding
|
US20100158837A1
(en)
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Iron oxide-binding peptides
|
US20100158846A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Hair-binding peptides
|
US20100158822A1
(en)
|
2008-12-18 |
2010-06-24 |
E .I. Du Pont De Nemours And Company |
Peptides that bind to silica-coated particles
|
US8287845B2
(en)
*
|
2008-12-18 |
2012-10-16 |
E I Du Pont De Nemours And Company |
Hair-binding peptides
|
CN101768213B
(zh)
|
2008-12-30 |
2012-05-30 |
中国科学院遗传与发育生物学研究所 |
一种与植物分蘖数目相关的蛋白及其编码基因与应用
|
DK3211126T3
(da)
|
2009-02-13 |
2020-12-21 |
X Chem Inc |
Fremgangsmåder til dannelse og screening af dna-kodede biblioteker
|
CN101817879A
(zh)
|
2009-02-26 |
2010-09-01 |
中国科学院遗传与发育生物学研究所 |
金属硫蛋白及其编码基因与应用
|
PE20160651A1
(es)
|
2009-03-05 |
2016-07-24 |
Abbvie Inc |
Proteinas de union a il-17
|
US8528589B2
(en)
|
2009-03-23 |
2013-09-10 |
Raindance Technologies, Inc. |
Manipulation of microfluidic droplets
|
BRPI1014677A2
(pt)
|
2009-03-30 |
2016-04-12 |
Du Pont |
sistemas baseados em peptídeos para distribuição de agentes cosméticos
|
WO2010114638A1
(en)
|
2009-03-30 |
2010-10-07 |
E. I. Du Pont De Nemours And Company |
Peptide-based tooth whitening reagents
|
US8067201B2
(en)
|
2009-04-17 |
2011-11-29 |
Bristol-Myers Squibb Company |
Methods for protein refolding
|
CN102459642A
(zh)
|
2009-04-24 |
2012-05-16 |
迪斯卡沃雷克斯公司 |
采用可检测蛋白质的细胞测定法
|
US9085798B2
(en)
|
2009-04-30 |
2015-07-21 |
Prognosys Biosciences, Inc. |
Nucleic acid constructs and methods of use
|
NZ598524A
(en)
|
2009-08-29 |
2014-06-27 |
Abbvie Inc |
Therapeutic dll4 binding proteins
|
IN2012DN02737A
(pt)
|
2009-09-01 |
2015-09-11 |
Abbott Lab |
|
WO2011032181A2
(en)
|
2009-09-14 |
2011-03-17 |
Dyax Corp. |
Libraries of genetic packages comprising novel hc cdr3 designs
|
US9284548B2
(en)
|
2009-10-05 |
2016-03-15 |
Tripep Ab |
High affinity adaptor molecules for redirecting antibody specifity
|
WO2011042564A1
(en)
|
2009-10-09 |
2011-04-14 |
Universite De Strasbourg |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
WO2011047262A2
(en)
|
2009-10-15 |
2011-04-21 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
JP5174971B2
(ja)
|
2009-10-22 |
2013-04-03 |
ペプチドリーム株式会社 |
ペプチド翻訳合成におけるrapidディスプレイ法
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
ES2691717T3
(es)
|
2009-10-30 |
2018-11-28 |
Novartis Ag |
Bibliotecas universales del dominio de unión del lado inferior de tipo iii de la fibronectina de tipo III
|
TW201121568A
(en)
|
2009-10-31 |
2011-07-01 |
Abbott Lab |
Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
|
JP2013509869A
(ja)
|
2009-11-05 |
2013-03-21 |
ノバルティス アーゲー |
線維症の進行の予測用バイオマーカー
|
CA2780024A1
(en)
|
2009-11-11 |
2011-05-19 |
Gentian As |
Immunoassay for assessing related analytes of different origin
|
EP2506861A1
(en)
|
2009-12-02 |
2012-10-10 |
Amgen Inc. |
Binding proteins that bind to human fgfr1c, human b-klotho and both human fgfr1c and human b-klotho
|
US20120270748A1
(en)
*
|
2009-12-07 |
2012-10-25 |
Prognosys Biosciences, Inc. |
Peptide display arrays
|
US9175075B2
(en)
|
2009-12-08 |
2015-11-03 |
AbbVie Deutschland GmbH & Co. KG |
Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein
|
WO2011079176A2
(en)
|
2009-12-23 |
2011-06-30 |
Raindance Technologies, Inc. |
Microfluidic systems and methods for reducing the exchange of molecules between droplets
|
LT2521568T
(lt)
|
2010-01-06 |
2018-12-10 |
Dyax Corp. |
Plazmos kalikreiną surišantys baltymai
|
IN2012DN06588A
(pt)
|
2010-02-10 |
2015-10-23 |
Novartis Ag |
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
JP5934657B2
(ja)
|
2010-02-12 |
2016-06-15 |
レインダンス テクノロジーズ, インコーポレイテッド |
デジタル検体分析
|
US8927693B2
(en)
|
2010-02-18 |
2015-01-06 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domain proteins that bind IL-23
|
CN105037543B
(zh)
|
2010-03-02 |
2020-11-03 |
Abbvie 公司 |
治疗性dll4结合蛋白
|
US10787701B2
(en)
|
2010-04-05 |
2020-09-29 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
CA2794522C
(en)
|
2010-04-05 |
2019-11-26 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
US20190300945A1
(en)
|
2010-04-05 |
2019-10-03 |
Prognosys Biosciences, Inc. |
Spatially Encoded Biological Assays
|
UY33331A
(es)
|
2010-04-13 |
2011-10-31 |
Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware |
Proteinas de dominio de armazon basadas en fibronectina que se unen a pcsk9
|
CA2796339C
(en)
|
2010-04-15 |
2020-03-31 |
Abbott Laboratories |
Amyloid-beta binding proteins
|
EP3540059A1
(en)
|
2010-04-16 |
2019-09-18 |
Nuevolution A/S |
Bi-functional complexes and methods for making and using such complexes
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
LT2571532T
(lt)
|
2010-05-14 |
2017-08-10 |
Abbvie Inc. |
Il-1 surišantys baltymai
|
EP3091028A1
(en)
|
2010-05-26 |
2016-11-09 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold proteins having improved stability
|
WO2012006500A2
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
AU2011279073B2
(en)
|
2010-07-16 |
2016-06-09 |
Adimab, Llc |
Antibody libraries
|
KR20130136443A
(ko)
|
2010-07-30 |
2013-12-12 |
노파르티스 아게 |
피브로넥틴 크레이들 분자 및 그의 라이브러리
|
AR082461A1
(es)
|
2010-08-03 |
2012-12-12 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
CA2808187A1
(en)
|
2010-08-14 |
2012-02-23 |
Abbvie Inc. |
Amyloid-beta binding proteins
|
RS63063B1
(sr)
|
2010-08-19 |
2022-04-29 |
Zoetis Belgium S A |
Anti-ngf antitela i njihova upotreba
|
KR20130139884A
(ko)
|
2010-08-26 |
2013-12-23 |
애브비 인코포레이티드 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
EP2622103B2
(en)
|
2010-09-30 |
2022-11-16 |
Bio-Rad Laboratories, Inc. |
Sandwich assays in droplets
|
CA3162352A1
(en)
|
2010-10-01 |
2012-04-05 |
Modernatx, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
WO2012052391A1
(en)
|
2010-10-19 |
2012-04-26 |
Glaxo Group Limited |
Polypeptide with jmjd3 catalytic activity
|
KR101931936B1
(ko)
|
2010-11-05 |
2018-12-26 |
에이자이 아이엔씨. |
엽산 수용체 알파-발현 암에 대한 진단 및 예후 마커로서의 엽산 수용체 알파
|
EP2647720B1
(en)
*
|
2010-12-03 |
2019-06-19 |
The University of Tokyo |
Peptide library production method, peptide library, and screening method
|
EP2647721B1
(en)
|
2010-12-03 |
2019-02-27 |
The University of Tokyo |
Peptide with safer secondary structure, peptide library, and production methods for same
|
WO2012088094A2
(en)
|
2010-12-21 |
2012-06-28 |
Abbott Laboratories |
Il-1 binding proteins
|
CA2821976A1
(en)
|
2010-12-21 |
2012-09-13 |
Abbvie Inc. |
Il-1 -alpha and -beta bispecific dual variable domain immunoglobulins and their use
|
WO2012088006A1
(en)
|
2010-12-22 |
2012-06-28 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domain proteins that bind il-23
|
DE102010056289A1
(de)
|
2010-12-24 |
2012-06-28 |
Geneart Ag |
Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
|
EP3859011A1
(en)
|
2011-02-11 |
2021-08-04 |
Bio-Rad Laboratories, Inc. |
Methods for forming mixed droplets
|
WO2012112804A1
(en)
|
2011-02-18 |
2012-08-23 |
Raindance Technoligies, Inc. |
Compositions and methods for molecular labeling
|
US9746475B2
(en)
|
2011-03-14 |
2017-08-29 |
University Of Southern California |
Antibody and antibody mimetic for visualization and ablation of endogenous proteins
|
ES2926988T3
(es)
|
2011-03-15 |
2022-10-31 |
X Body Inc |
Métodos de cribado de anticuerpos
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
US20120258871A1
(en)
|
2011-04-08 |
2012-10-11 |
Prognosys Biosciences, Inc. |
Peptide constructs and assay systems
|
PT2697257T
(pt)
|
2011-04-13 |
2016-12-28 |
Bristol Myers Squibb Co |
Proteínas de fusão fc compreendendo novos ligantes ou arranjos
|
GB201106254D0
(en)
|
2011-04-13 |
2011-05-25 |
Frisen Jonas |
Method and product
|
CN117026386A
(zh)
|
2011-04-28 |
2023-11-10 |
小利兰斯坦福大学托管委员会 |
与样品相关的多核苷酸的鉴定
|
EP2710382B1
(en)
|
2011-05-17 |
2017-10-18 |
Bristol-Myers Squibb Company |
Improved methods for the selection of binding proteins
|
US20140187488A1
(en)
|
2011-05-17 |
2014-07-03 |
Bristol-Myers Squibb Company |
Methods for maintaining pegylation of polypeptides
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
EP3709018A1
(en)
|
2011-06-02 |
2020-09-16 |
Bio-Rad Laboratories, Inc. |
Microfluidic apparatus for identifying components of a chemical reaction
|
AU2012262007B2
(en)
|
2011-06-02 |
2017-06-22 |
Takeda Pharmaceutical Company Limited |
Fc receptor binding proteins
|
US20140369934A1
(en)
|
2011-06-02 |
2014-12-18 |
Massachusetts Institute Of Technology |
dsRNA/DNA Hybrid Genome Replication Intermediate Of Metakaryotic Stem Cells
|
CA2841970A1
(en)
|
2011-07-13 |
2013-01-17 |
Abbvie Inc. |
Methods and compositions for treating asthma using anti-il-13 antibodies
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
CA2843955A1
(en)
|
2011-08-01 |
2013-02-07 |
The General Hospital Corporation |
Protein and peptide libraries
|
EP2748357B1
(en)
|
2011-09-07 |
2018-04-04 |
X-Chem, Inc. |
Methods for tagging dna-encoded libraries
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
US9428535B2
(en)
|
2011-10-03 |
2016-08-30 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
CN104093739A
(zh)
|
2011-10-24 |
2014-10-08 |
艾伯维公司 |
针对tnf的免疫结合剂
|
TW201323440A
(zh)
|
2011-10-24 |
2013-06-16 |
Abbvie Inc |
抗骨硬化素(sclerostin)之免疫結合物
|
EP2773659A2
(en)
|
2011-10-31 |
2014-09-10 |
Bristol-Myers Squibb Company |
Fibronectin binding domains with reduced immunogenicity
|
TWI591074B
(zh)
|
2011-12-05 |
2017-07-11 |
X 染色體有限公司 |
PDGF受體β結合多肽
|
CA2855840C
(en)
|
2011-12-14 |
2023-08-29 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
EP2791175A2
(en)
|
2011-12-14 |
2014-10-22 |
Abbvie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
EP2791160B1
(en)
|
2011-12-16 |
2022-03-02 |
ModernaTX, Inc. |
Modified mrna compositions
|
TWI713889B
(zh)
*
|
2011-12-28 |
2020-12-21 |
中外製藥股份有限公司 |
胜肽化合物之環化方法
|
CA2861610A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbvie Inc. |
Dual specific binding proteins directed against il-13 and/or il-17
|
SG10202006762PA
(en)
|
2012-01-27 |
2020-08-28 |
Abbvie Deutschland |
Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
|
GB2500243A
(en)
*
|
2012-03-15 |
2013-09-18 |
Isogenica Ltd |
Identifying members of immobilised peptide libraries comprising protein-DNA complexes
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
AU2013243946A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of membrane proteins
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
CN114163530A
(zh)
|
2012-04-20 |
2022-03-11 |
美勒斯公司 |
用于产生免疫球蛋白样分子的方法和手段
|
WO2013172954A1
(en)
|
2012-05-17 |
2013-11-21 |
Ra Pharmaceuticals, Inc |
Peptide and peptidomimetic inhibitors
|
CN104364264B
(zh)
|
2012-06-06 |
2018-07-24 |
硕腾服务有限责任公司 |
犬源化抗ngf抗体和其方法
|
UY34905A
(es)
|
2012-07-12 |
2014-01-31 |
Abbvie Inc |
Proteínas de unión a il-1
|
KR102146721B1
(ko)
|
2012-07-13 |
2020-08-21 |
엑스-켐, 인크. |
폴리머라제에 의해 판독가능하지 않은 코딩 올리고뉴클레오티드 연결을 갖는 dna-코딩된 라이브러리
|
CN104768969B
(zh)
|
2012-09-13 |
2021-04-16 |
百时美施贵宝公司 |
结合至肌生成抑制素的基于纤连蛋白的支架结构域蛋白
|
KR20210111353A
(ko)
|
2012-11-01 |
2021-09-10 |
애브비 인코포레이티드 |
항-vegf/dll4 이원 가변 도메인 면역글로불린 및 이의 용도
|
LT2922554T
(lt)
|
2012-11-26 |
2022-06-27 |
Modernatx, Inc. |
Terminaliai modifikuota rnr
|
US9550986B2
(en)
|
2012-12-21 |
2017-01-24 |
Abbvie Inc. |
High-throughput antibody humanization
|
JPWO2014119600A1
(ja)
|
2013-01-30 |
2017-01-26 |
ペプチドリーム株式会社 |
FlexibleDisplay法
|
WO2014120891A2
(en)
|
2013-02-01 |
2014-08-07 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold proteins
|
ES2689372T3
(es)
|
2013-02-06 |
2018-11-13 |
Bristol-Myers Squibb Company |
Proteínas de dominio de fibronectina tipo III con solubilidad mejorada
|
EP3617220B1
(en)
|
2013-02-12 |
2021-03-24 |
Bristol-Myers Squibb Company |
High ph protein refolding methods
|
DK2962100T3
(da)
|
2013-02-28 |
2021-11-01 |
Caprion Proteomics Inc |
Tuberkulosebiomarkører og anvendelser deraf
|
WO2014165093A2
(en)
|
2013-03-13 |
2014-10-09 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
|
CA2906421C
(en)
|
2013-03-14 |
2022-08-16 |
George J. Dawson |
Hcv antigen-antibody combination assay and methods and compositions for use therein
|
CN105209616A
(zh)
|
2013-03-14 |
2015-12-30 |
雅培制药有限公司 |
用于改进的抗体检测的hcv ns3重组抗原及其突变体
|
US10132816B2
(en)
|
2013-03-14 |
2018-11-20 |
Beth Israel Deaconess Medical Center, Inc. |
Measurement of FGF21 as a biomarker of fructose metabolism
|
US9371374B2
(en)
|
2013-03-14 |
2016-06-21 |
Abbott Laboratories |
HCV core lipid binding domain monoclonal antibodies
|
JP2016522793A
(ja)
|
2013-03-15 |
2016-08-04 |
アッヴィ・インコーポレイテッド |
IL−1βおよび/またはIL−17に対して指向された二重特異的結合タンパク質
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
CA2907050C
(en)
|
2013-03-15 |
2023-09-26 |
Prognosys Biosciences, Inc. |
Methods for detecting peptide/mhc/tcr binding
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
EP2999796B1
(en)
|
2013-05-20 |
2017-10-25 |
BioVentures, LLC |
Gep5 model for multiple myeloma
|
EP3003372B1
(en)
|
2013-06-07 |
2019-10-09 |
Duke University |
Inhibitors of complement factor h
|
EP3013984B1
(en)
|
2013-06-25 |
2023-03-22 |
Prognosys Biosciences, Inc. |
Methods for determining spatial patterns of biological targets in a sample
|
SG10201806428YA
(en)
|
2013-06-28 |
2018-08-30 |
X Body Inc |
Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
|
US20160194625A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
US10519436B2
(en)
|
2013-09-23 |
2019-12-31 |
X-Body, Inc. |
Methods and compositions for generation of binding agents against cell surface antigens
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
CA2926218A1
(en)
|
2013-10-03 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
WO2015070037A2
(en)
|
2013-11-08 |
2015-05-14 |
Prognosys Biosciences, Inc. |
Polynucleotide conjugates and methods for analyte detection
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
ES2918501T3
(es)
|
2013-12-19 |
2022-07-18 |
Novartis Ag |
Receptores de antígenos quiméricos de mesotelina humana y usos de los mismos
|
GB201322692D0
(en)
|
2013-12-20 |
2014-02-05 |
Philochem Ag |
Production of encoded chemical libraries
|
WO2015103367A1
(en)
|
2013-12-31 |
2015-07-09 |
Raindance Technologies, Inc. |
System and method for detection of rna species
|
US10421958B2
(en)
|
2014-02-05 |
2019-09-24 |
Molecular Templates, Inc. |
Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
|
CA2943228C
(en)
|
2014-03-20 |
2023-03-14 |
Bristol-Myers Squibb Company |
Stabilized fibronectin based scaffold molecules
|
KR102472862B1
(ko)
|
2014-03-20 |
2022-12-05 |
브리스톨-마이어스 스큅 컴퍼니 |
혈청 알부민-결합 피브로넥틴 유형 iii 도메인
|
BR112016029076B1
(pt)
|
2014-06-12 |
2024-02-15 |
Ra Pharmaceuticals, Inc |
Polipeptídeo e composição compreendendo o mesmo para inibir a clivagem de c5 em um sistema celular
|
CN114057857A
(zh)
|
2014-06-20 |
2022-02-18 |
豪夫迈·罗氏有限公司 |
基于chagasin的支架组合物、方法和应用
|
CA2955250A1
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
KR102594343B1
(ko)
|
2014-07-21 |
2023-10-26 |
노파르티스 아게 |
Cd33 키메라 항원 수용체를 사용한 암의 치료
|
EP3180359A1
(en)
|
2014-08-14 |
2017-06-21 |
Novartis AG |
Treatment of cancer using gfr alpha-4 chimeric antigen receptor
|
SG11201700770PA
(en)
|
2014-08-19 |
2017-03-30 |
Novartis Ag |
Anti-cd123 chimeric antigen receptor (car) for use in cancer treatment
|
MA40773A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus influenza a
|
MA40772A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus de la grippe a
|
JP6701217B2
(ja)
|
2014-11-25 |
2020-05-27 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
生物学的製剤の18f−放射性標識方法および組成物
|
CN114591420A
(zh)
|
2014-11-25 |
2022-06-07 |
百时美施贵宝公司 |
用于成像的新型pd-l1结合多肽
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
PL3250230T3
(pl)
|
2015-01-28 |
2022-02-14 |
Ra Pharmaceuticals, Inc. |
Modulatory aktywności dopełniacza
|
EP3061826A1
(en)
|
2015-02-27 |
2016-08-31 |
Novartis AG |
Flavivirus replicons
|
EP4166664A1
(en)
|
2015-03-13 |
2023-04-19 |
Chugai Seiyaku Kabushiki Kaisha |
Modified aminoacyl-trna synthetase and use thereof
|
EP3901282B1
(en)
|
2015-04-10 |
2023-06-28 |
Spatial Transcriptomics AB |
Spatially distinguished, multiplex nucleic acid analysis of biological specimens
|
CN108472360B
(zh)
|
2015-04-10 |
2023-01-17 |
阿迪马布有限责任公司 |
从亲代同源二聚抗体种类中纯化异源二聚多特异性抗体的方法
|
CN104774801A
(zh)
*
|
2015-04-14 |
2015-07-15 |
云南农业大学 |
一种核酸核糖体结合体系构建方法及应用
|
JP6894846B2
(ja)
|
2015-04-24 |
2021-06-30 |
ヴィーブ ヘルスケア ユーケー(ナンバー5)リミテッド |
Hiv融合体を標的とするポリペプチド
|
CA2980189A1
(en)
|
2015-04-24 |
2016-10-27 |
Genentech, Inc. |
Multispecific antigen-binding proteins
|
UY36692A
(es)
|
2015-05-29 |
2016-12-30 |
Abbvie Inc |
Anticuerpos anti-cd40 y usos de los mismos
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
US20190008887A1
(en)
*
|
2015-07-30 |
2019-01-10 |
ModernaTX Inc. |
Multimeric mrna
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
US10584160B2
(en)
|
2015-09-23 |
2020-03-10 |
Bristol-Myers Squibb Company |
Glypican-3-binding fibronectin based scaffold molecules
|
KR20180056701A
(ko)
|
2015-09-23 |
2018-05-29 |
브리스톨-마이어스 스큅 컴퍼니 |
패스트-오프 레이트 혈청 알부민 결합 피브로넥틴 유형 iii 도메인
|
LT3389692T
(lt)
|
2015-12-16 |
2020-04-27 |
Ra Pharmaceuticals, Inc. |
Komplemento aktyvumo moduliatoriai
|
MA44483A
(fr)
|
2016-03-24 |
2019-01-30 |
Millennium Pharm Inc |
Procédés pour traiter des événements indésirables gastro-intestinaux d'origine immunitaire dans des traitements oncologiques immunitaires
|
WO2017165742A1
(en)
|
2016-03-24 |
2017-09-28 |
Millennium Pharmaceuticals, Inc. |
Methods of treating gastrointestinal immune-related adverse events in anti-ctla4 anti-pd-1 combination treatments
|
EP4299803A3
(en)
*
|
2016-05-02 |
2024-03-27 |
Encodia, Inc. |
Macromolecule analysis employing nucleic acid encoding
|
US10994033B2
(en)
|
2016-06-01 |
2021-05-04 |
Bristol-Myers Squibb Company |
Imaging methods using 18F-radiolabeled biologics
|
JP7016323B2
(ja)
|
2016-06-01 |
2022-02-21 |
ブリストル-マイヤーズ スクイブ カンパニー |
Pd-l1結合ポリペプチドを用いるpet造影
|
EP3475446A1
(en)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
CA3030837A1
(en)
|
2016-07-15 |
2018-01-18 |
Novartis Ag |
Treatment and prevention of cytokine release syndrome using a chimeric antigen receptor in combination with a kinase inhibitor
|
JP2019535015A
(ja)
|
2016-10-03 |
2019-12-05 |
アボット・ラボラトリーズAbbott Laboratories |
患者サンプルにおけるgfap状況を評価する改善された方法
|
US10525083B2
(en)
|
2016-10-07 |
2020-01-07 |
Novartis Ag |
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
|
BR112019011053A2
(pt)
|
2016-12-07 |
2019-10-15 |
Ra Pharmaceuticals Inc |
moduladores da atividade do complemento
|
US11382983B2
(en)
|
2017-01-13 |
2022-07-12 |
Academia Sinica |
Reloadable hydrogel system for treating brain conditions
|
TWI659750B
(zh)
|
2017-01-13 |
2019-05-21 |
中央研究院 |
用以治療心肌梗塞之可重複裝載之改良水膠系統
|
AU2018236568B2
(en)
*
|
2017-03-17 |
2021-07-01 |
Cubicstars, Inc. |
Method for producing complex of RNA molecule and peptide, and utilization thereof
|
JP7346300B2
(ja)
|
2017-03-23 |
2023-09-19 |
アボット・ラボラトリーズ |
早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼl1を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法
|
AU2018250688A1
(en)
|
2017-04-15 |
2019-08-29 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
WO2018200823A1
(en)
|
2017-04-28 |
2018-11-01 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
AU2018272054A1
(en)
|
2017-05-25 |
2019-09-26 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
EP3933408A1
(en)
|
2017-05-30 |
2022-01-05 |
Nant Holdings IP LLC |
Circulating tumor cell enrichment using neoepitopes
|
CN110709704A
(zh)
|
2017-05-30 |
2020-01-17 |
雅培实验室 |
利用心肌肌钙蛋白i辅助诊断和评估人类受试者的轻度创伤性脑损伤的方法
|
JP7229158B2
(ja)
|
2017-06-09 |
2023-02-27 |
中外製薬株式会社 |
N-置換アミノ酸を含むペプチドの合成方法
|
JP7454945B2
(ja)
|
2017-07-03 |
2024-03-25 |
アボット・ラボラトリーズ |
血液中のユビキチンカルボキシ末端ヒドロラーゼl1レベルを測定するための、改善された方法
|
WO2019070161A2
(en)
|
2017-10-04 |
2019-04-11 |
Opko Pharmaceuticals, Llc |
ARTICLES AND METHODS FOR PERSONALIZED THERAPY OF CANCER
|
AU2018358057B2
(en)
*
|
2017-10-31 |
2023-03-02 |
Encodia, Inc. |
Kits for analysis using nucleic acid encoding and/or label
|
BR112020010085A2
(pt)
|
2017-12-09 |
2020-10-13 |
Abbott Laboratories |
métodos para auxiliar no diagnóstico e avaliar uma lesão cerebral traumática em um indivíduo humano usando uma combinação de gfap e uch-l1
|
JP7344801B2
(ja)
|
2017-12-09 |
2023-09-14 |
アボット・ラボラトリーズ |
グリア原線維性酸性タンパク質(gfap)及び/又はユビキチンカルボキシ末端ヒドロラーゼl1(uch-l1)を使用する、整形外科損傷を負っており、軽度外傷性脳損傷(tbi)などの頭部への損傷を負ったか又は負った可能性がある対象についての診断及び査定の一助となるための方法
|
US11492369B2
(en)
|
2017-12-15 |
2022-11-08 |
Chugai Seiyaku Kabushiki Kaisha |
Method for producing peptide, and method for processing bases
|
EP3728310A1
(en)
|
2017-12-18 |
2020-10-28 |
VIIV Healthcare UK (No.5) Limited |
Antigen binding polypeptides
|
EP3765499A1
(en)
|
2018-03-12 |
2021-01-20 |
Zoetis Services LLC |
Anti-ngf antibodies and methods thereof
|
WO2019190954A1
(en)
|
2018-03-26 |
2019-10-03 |
Rootpath Genomics, Inc. |
Target binding moiety compositions and methods of use
|
EP3889164A4
(en)
|
2018-11-30 |
2022-11-02 |
Chugai Seiyaku Kabushiki Kaisha |
DEPROTECTION METHODS AND RESIN REMOVAL METHODS IN THE SOLID PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND AND METHODS FOR PRODUCTION OF A PEPTIDE COMPOUND
|
EP4253422A3
(en)
*
|
2019-02-15 |
2023-12-06 |
Atreca, Inc. |
Antibodies that bind tumor tissue, and their diagnostic and therapeutic uses
|
WO2020198731A2
(en)
|
2019-03-28 |
2020-10-01 |
Danisco Us Inc |
Engineered antibodies
|
CN113795514A
(zh)
|
2019-05-09 |
2021-12-14 |
豪夫迈·罗氏有限公司 |
制备抗体的方法
|
JP2022544785A
(ja)
|
2019-08-13 |
2022-10-21 |
エルピス・バイオファーマシューティカルズ |
改変インターロイキン2受容体ベータアゴニスト
|
EP4055185A1
(en)
|
2019-11-08 |
2022-09-14 |
10X Genomics, Inc. |
Spatially-tagged analyte capture agents for analyte multiplexing
|
US20230061973A1
(en)
|
2020-02-05 |
2023-03-02 |
Larimar Therapeutics, Inc. |
Tat peptide binding proteins and uses thereof
|
JP2023515633A
(ja)
|
2020-02-28 |
2023-04-13 |
ブリストル-マイヤーズ スクイブ カンパニー |
放射性標識されたフィブロネクチンに基づく足場および抗体ならびにそのセラノスティクス的使用
|
CA3175523A1
(en)
|
2020-04-13 |
2021-10-21 |
Antti Virtanen |
Methods, complexes and kits for detecting or determining an amount of a .beta.-coronavirus antibody in a sample
|
US20220033459A1
(en)
|
2020-07-31 |
2022-02-03 |
Nantbio, Inc. |
Chimeric T Cell Receptors, Nucleic Acids, And Methods Of Making And Using The Same
|
WO2022031804A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Laboratories |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
WO2022104001A1
(en)
|
2020-11-13 |
2022-05-19 |
Bristol-Myers Squibb Company |
Expanded protein libraries and uses thereof
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
US20220170948A1
(en)
|
2020-12-01 |
2022-06-02 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi
|
WO2022140028A1
(en)
|
2020-12-21 |
2022-06-30 |
10X Genomics, Inc. |
Methods, compositions, and systems for capturing probes and/or barcodes
|
WO2022147147A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
JP2024504372A
(ja)
|
2021-01-22 |
2024-01-31 |
エルピス・バイオファーマシューティカルズ |
抗pd-l1モノクローナル抗体及びインターロイキン15(il-15)、インターロイキン15受容体15アルファまたはインターロイキン2との融合タンパク質
|
US11792839B2
(en)
|
2021-03-12 |
2023-10-17 |
Eagle Technology, Llc |
Systems and methods for controlling communications based on machine learned information
|
EP4301870A1
(en)
|
2021-03-18 |
2024-01-10 |
10X Genomics, Inc. |
Multiplex capture of gene and protein expression from a biological sample
|
EP4341699A1
(en)
|
2021-05-18 |
2024-03-27 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
EP4356129A1
(en)
|
2021-06-14 |
2024-04-24 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
WO2023034777A1
(en)
|
2021-08-31 |
2023-03-09 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
CA3232176A1
(en)
|
2021-09-30 |
2023-04-06 |
Beth MCQUISTON |
Methods and systems of diagnosing brain injury
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
US20230213536A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
WO2023220597A1
(en)
|
2022-05-10 |
2023-11-16 |
Elpis Biopharmaceuticals |
Engineered interleukin-2 receptor beta reduced-binding agonist
|
WO2024006876A1
(en)
|
2022-06-29 |
2024-01-04 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|